BALDWIN PARK, Calif., May 11, 2021 /PRNewswire/ -- California-based StemCyte is pleased to announce expanded hours for umbilical cord blood collection at three hospital sites inSouthern California.Made possible through a partnership between StemCyte and UC Davis Health, additional funding will be provided to grow the cord blood program by adding highly trained collection staff, and by identifying and educating cord blood 'champions' at the sites to help facilitate and advance this important work. Located in the cities of Los Angeles, Ontario and Fontana, the collection sites will have additional staff to collect cord blood during extended evening shifts. As these sites employ a hybrid collector-physician model, physicians and midwives will continue to collect cord blood afterhours. This added coverage to each site allows StemCyte to be able to offer more patients the opportunity to participate in California's Umbilical Cord Blood Collection Program.
This Umbilical Cord Blood Collection Program (UCBCP) is aCalifornia statewide program administered by UC Davis Health. The goal of UCBCP is to increase the number of high-quality, publicly banked umbilical cord blood units and make them available to anyone for lifesaving transplantations. StemCyte has been collaborating with UC Davis Health on the program since 2012. This additional increase in support sets the stage for a dramatic increase in quality cord blood collections from a diverse donor base that is unique to Southern California.
As aCalifornia-based hybrid public and private cord blood banking company with over 23 years' experience and a strong research focus, StemCyte stands ready as the optimal fit for this collaboration. The newborn stem cells collected from the cord blood will be processed and stored with the highest quality standards in the industry. "It is a great honor and privilege for StemCyte to be partnered with UC Davis for California's Umbilical Cord Blood Program (UCBCP). We are proud of the work we have done to provide nearly 90% of the high quality and genetically diverse units selected for transplant from the state. The ability to extend collection coverage at these three sites will not only broaden opportunities for expectant parents to donate their babies' cord blood, but it is also likely to increase the genetic diversity of cord blood units that are added to the public registry. We are determined to work closely with physicians and staff through continuing support for this program to achieve its goals. StemCyte is one of the most accredited cord blood banks in the world and is the leading hybrid bank in California, which provides services for public banking as well as private banking," said Dr.Tong-Young Lee, CEO of StemCyte.
AboutCalifornia'sUmbilical Cord Blood Collection Program (UCBCP)
California'sUmbilical Cord Blood Collection Program (UCBCP) is a statewide program administered by UC Davis Health inSacramento. The collection service is the state's first comprehensive public system for collecting cord blood that will be stored at an established, qualified cord blood bank like StemCyte. Mothers can donate their newborns' umbilical cord blood, and have it publicly banked so it is available to anyone for lifesaving transplantations.
About StemCyte
StemCyte's rich history started with a mission of dedication to helping the world's physicians save more lives by providing high quality, safe and effective stem cell transplantation and therapy to all patients in need. Located in the US,India,andTaiwan, StemCyte has supplied over 2100 cord blood units for a variety of life-threatening diseases to over 300 leading worldwide transplant centers. StemCyte is actively involved in the development of stem cell therapies. StemCyte was chosen by the US Department of Health and Human Services to help establish a public National Cord Blood Inventory. Its headquarters are inBaldwin Park, CA.To learn more, visitwww.StemCyte.com or call 626.646.2500.
SOURCE StemCyte
Excerpt from:
- Constructing a potential HLA haplo-homozygous induced pluripotent stem ... - February 6th, 2025
- Banking on iPSCs | The Scientist - January 28th, 2025
- I Peace manufactures 100 lines of GMP iPS Cells cumulatively - PR Newswire - January 1st, 2025
- Cell banking: Definition, Process & Manufacturing - December 27th, 2024
- Stem cell banking: benefits and challenges - faCellitate - December 25th, 2024
- Stem Cell Banking Market to Surpass Value of USD 18.65 - GlobeNewswire - December 17th, 2024
- Stem Cell Banking Market Types and Applications, Drivers, - openPR - December 13th, 2024
- Human Pluripotent Stem Cell Banking - December 5th, 2024
- Cord Blood Banking 101: What Expectant Parents Need to Know - DNA India - December 5th, 2024
- Stem Cell Banking Market by Type, Service, Source, Application - Global ... - November 29th, 2024
- ViaCord Cord Blood Banking - November 25th, 2024
- What Is Stem Cell Banking? - Celltex Therapeutics Corporation - November 22nd, 2024
- Stem Cell/Cord Blood Banking Market Size, Trend Analysis, Share, Competitive Analysis, And Forecast To 2033 - openPR - November 20th, 2024
- Medeze Group Reaffirms Its International Standards Degree of Stem Cell Banking Services - KAOHOON INTERNATIONAL - November 8th, 2024
- Adult Stem Cells Storage & Banking | Preserve Stem Cells Forever Labs - October 27th, 2024
- International Stem Cell Banking Initiative - October 27th, 2024
- SBS University hosts National Workshop on Stem Cell Banking - Garhwal Post - October 20th, 2024
- Stem Cell Banking Market Advancements and Opportunities in Cell Preservation and Research - openPR - October 18th, 2024
- The global leader in personal stem cell banking - October 15th, 2024
- Stem Cell Banking Outsourcing Industry to Witness Massive Growth (2024-2034) |CCBC, CBR, ViaCord, Esperite, Vcanbio, Boy Talented India - Talented... - October 15th, 2024
- Medeze, a stem cell banking service provider, will start trading on the Stock Exchange of Thailand on October 15 - Thailand Business News - October 15th, 2024
- Stem Cell Banking: Current Trends, Benefits, Emerging Issues and ... - October 14th, 2024
- Fundamental Principles of Stem Cell Banking - PubMed - October 11th, 2024
- Cell Bank Production - ATCC - October 10th, 2024
- Stem Cell Banking Market Size Projected to Reach USD 16.55 Billion, Globally, by 2030 at 15.6% CAGR - EIN News - October 10th, 2024
- The Growing Importance of Stem Cell Banking in the UAE - October 4th, 2024
- American Cell Technology | Stem Cell Banking in the United States - September 30th, 2024
- Cell Banking - About Stem Cells - September 30th, 2024
- What to Know about Stem Cell Banking & Storage for Future Health - September 30th, 2024
- What is Stem Cell Banking? - azolifesciences.com - September 30th, 2024
- Stem Cell Banking Market Growth and Innovation 2024: Business - openPR - July 10th, 2024
- Stem Cell Banking Market Size To Surpass USD 19.29 Billion By 2030, Exhibiting A CAGR Of 13.69% As Revealed... - WhaTech - March 18th, 2024
- Stem Cell Banking Market Size, Share, Competitive Landscape and Trend Analysis and Industry Forecast, - EIN News - January 18th, 2024
- Stem Cell Banking Market Predicted to Witness Steady Growth ... - Digital Journal - September 8th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | CAGR 15.6% - EIN News - September 7th, 2023
- Stem Cell Banking Market Trends: Industry Analysis and Growth Projections Through 2030 - Benzinga - September 3rd, 2023
- Stem Cell Banking Market Report: Analysis of Effective Business ... - Digital Journal - August 30th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | CAGR of 15.6% - openPR - July 19th, 2023
- Stem Cell Banking Market expected to reach USD 16,474.30 million by 2029 - openPR - July 8th, 2023
- Global Stem Cell Banking Market is expected to reach a market size of ~US$ 15 billion by 2028: Ken Research - openPR - June 8th, 2023
- Stem Cell Banking Market: CAGR of 8.2% and Market Valuation ... - KaleidoScot - June 8th, 2023
- Cord Stem Cell Banking Market Size to Surpass USD 45.64 Billion with CAGR of 22% by 2030 - openPR - June 4th, 2023
- Forecasting the Future of the Stem Cell Banking Market : Trends and Insights | CCBC, Crioestaminal, Esperite, - openPR - April 29th, 2023
- Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | Current Trends and Industry Analysis - EIN News - April 27th, 2023
- Stem Cell Banking Offers Health And Investment Opportunity - ValueWalk - April 21st, 2023
- Stem Cell Banking Offers Health and Investment Opportunity ... - SavingAdvice.com - April 19th, 2023
- Cord Stem Cell Banking Market to Influence the Value of USD 45.64 Billion by 2030 - openPR - April 12th, 2023
- Stem Cell Banking Market Size Expected to Reach USD 16,474.30 Million by 2029 with 16.1% CAGR - openPR - March 29th, 2023
- What is Stem Cell Banking? | Cells4Life - March 19th, 2023
- What is Stem Cell Banking? | Cells4Life - March 19th, 2023
- Stem Cell Banking Market Top-Players And Qualitative Future ... - Digital Journal - February 13th, 2023
- Global Stem Cell Banking Market Overview, Regional Analysis, Market Share and Competitive Analysis - openPR - February 4th, 2023
- What is Stem Cell Banking? | Stem Cell Preservation in India | Stem ... - January 7th, 2023
- Stem Cell & Cord Blood Banking Dubai, UAE - CellSave Arabia - January 5th, 2023
- Donate Stem Cells | Bone Marrow Donation - American Cancer Society - January 5th, 2023
- Private stem cell banking & genetic screening | Future Health Biobank - December 24th, 2022
- Stem Cell Banking Outsourcing Market is anticipated to expand at a ... - Digital Journal - December 20th, 2022
- Stem Cell Banking market size is estimated to be worth USD 1789 million in 2021 and is forecast to a readjuste - openPR - December 15th, 2022
- Stem Cell Banking Market To Reach USD 2927.2 Million By 2028 With A CAGR of 7.2% | Valuates Reports - Yahoo Finance - December 11th, 2022
- Stem Cell Banking Market registering a CAGR of 16.1% by forecast 2029 - openPR - December 1st, 2022
- Stem Cell Banking Industry 2022 - 2028 Market Analysis by Regions, Types and Application - openPR - November 6th, 2022
- Stem Cell Banking & Therapy In India | ReeLabs - October 25th, 2022
- Worldwide Stem Cell Banking Industry to 2027 - Rising Number of Fatal ... - October 25th, 2022
- Global Stem Cell Umbilical Cord Blood (UCB) Market Report 2022-2026: Increased Federal Investment in Stem Cell Therapy, and the Advent of Cord Blood... - October 25th, 2022
- Placental Stem Cell Therapy Market - Know the Latest Profit Sources of the Industry - openPR - October 18th, 2022
- Outlook on the Cord Blood Banking Services Global Market to 2027 - by Component, Storage Services, Application and Region - GlobeNewswire - October 13th, 2022
- Cell & Tissue Preservation Market Size will Observe Lucrative Surge by the End 2031 - openPR - October 12th, 2022
- News from the world of Education: October 12, 2022 - The Hindu - October 12th, 2022
- Stemcord | Home - October 9th, 2022
- Global Cord Blood Banking Market - Competition Forecast and Opportunities, 2027 - Yahoo Finance - October 9th, 2022
- Cell Banking Outsourcing Market Analysis By Trends, Size, Share, Company Overview, Growth And Forecast By 2031 The Colby Echo News - The Colby Echo... - October 4th, 2022
- Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands - Business Wire - September 29th, 2022
- Biobanking Market Size to Surge at the CAGR of 5.9% from 2022-2031 - Digital Journal - September 19th, 2022
- Stem Cell Banking Solutions | Hope Biosciences - September 19th, 2022
- Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets - Benzinga - September 17th, 2022
- Stem Cell Banking Market to Witness Massive Growth by 2029 | CCBC, CBR - Fighting Hawks Magazine - Fighting Hawks Magazine - September 15th, 2022
- Stem Cell Banking Market Analysis, 2031: Advancements in the field of Regenerative Medicine - BioSpace - September 15th, 2022
- Stem Cell Therapy Market worth $558 million by 2027 Exclusive Report by MarketsandMarkets - GlobeNewswire - September 15th, 2022
- Cord Blood Banking Services Market Size Estimated to Reach $3.6 Billion By 2027 at a CAGR of 11.8% During Forecast Period 2022-2027. - Digital Journal - August 30th, 2022
- Applied StemCell expands manufacturing facility to support cell and gene therapies - BioPharma-Reporter.com - August 30th, 2022
Recent Comments